We are live on
!
Find out more
DG
Delek Group Portfolio holdings
AUM
$2.59B
1-Year Est. Return
1.24%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
+$213M
(+9.7%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
23.02%
Holding
258
New
42
Increased
72
Reduced
68
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$30.9M |
| 2 |
International Flavors & Fragrances
IFF
|
+$25.9M |
| 3 |
Owens Corning
OC
|
+$24.4M |
| 4 |
Nu Skin
NUS
|
+$22.7M |
| 5 |
Capri Holdings
CPRI
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$24.9M |
| 2 |
Ormat Technologies
ORA
|
+$23.7M |
| 3 |
SolarEdge
SEDG
|
+$19.6M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$17.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.57% |
| 2 | Technology | 15.73% |
| 3 | Healthcare | 14.58% |
| 4 | Energy | 9.98% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CVS Health
CVS
$119B
| $1.53M | 0.06% |
+28,501
| New | +$1.76M |
|
152
iShares Floating Rate Bond ETF
FLOT
$10.6B
| $1.52M | 0.06% |
29,956
-20,640
| -41% | -$1.05M |
|
153
Microsoft
MSFT
$3.84T
| $1.52M | 0.06% |
12,975
-1,118
| -8% | -$122K |
|
154
Alibaba
BABA
$294B
| $1.51M | 0.06% |
8,323
-840
| -9% | -$141K |
|
|
ORBK
155
DELISTED
Orbotech Ltd
ORBK
| $1.5M | 0.06% |
+22,873
| New | +$1.37M |
|
156
Amgen
AMGN
$234B
| $1.4M | 0.06% |
7,398
-446
| -6% | -$85.2K |
|
157
Cisco
CSCO
$435B
| $1.38M | 0.06% |
25,695
-7,873
| -23% | -$383K |
|
158
TAT Technologies
TATT
$474M
| $1.37M | 0.06% |
226,570
+4,404
| +2% | +$28.7K |
|
159
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
| $1.34M | 0.06% |
24,001
-11,837
| -33% | -$633K |
|
160
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.89B
| $1.25M | 0.05% |
17,719
+5,396
| +44% | +$368K |
|
161
CALL
Perrigo
PRGO
$1.99B
| $1.2M | 0.05% |
27,000
-18,400
| -41% | -$861K |
|
162
Textron
TXT
$14.2B
| $1.09M | 0.05% |
21,671
-2,641
| -11% | -$136K |
|
163
Boeing
BA
$165B
| $1.06M | 0.04% |
+2,789
| New | +$1.07M |
|
164
LivePerson
LPSN
$33.2M
| $867K | 0.04% |
2,001
-10,340
| -84% | -$3.87M |
|
165
Varonis Systems
VRNS
$5.12B
| $861K | 0.04% |
+43,512
| New | +$826K |
|
166
iShares JPMorgan EM Corporate Bond ETF
CEMB
$435M
| $735K | 0.03% |
+14,809
| New | +$725K |
|
167
Five Below
FIVE
$13.5B
| $726K | 0.03% |
+5,868
| New | +$711K |
|
|
FSCT
168
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $722K | 0.03% |
+17,311
| New | +$621K |
|
169
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.68B
| $716K | 0.03% |
+15,346
| New | +$708K |
|
170
Stratasys
SSYS
$681M
| $676K | 0.03% |
+28,506
| New | +$686K |
|
171
Centene
CNC
$31.9B
| $626K | 0.03% |
+11,853
| New | +$719K |
|
172
PUT
Radware
RDWR
$1.21B
| $601K | 0.03% |
+23,000
| New | +$561K |
|
|
NNDM
173
Nano Dimension
NNDM
$333M
| $594K | 0.02% |
84,115
+79,468
| +1,710% | +$755K |
|
174
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.6B
| $564K | 0.02% |
10,317
-903
| -8% | -$48.7K |
|
|
PHXM
175
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $528K | 0.02% |
7,000
| – | – |
|
Similar funds
KPAG
HIM
GAM
CAM
CI
LC
LIC
CB
Delek Group's Q1 2019 Portfolio in Review
As of Q1 2019, Delek Group held 258 positions worth $2.41B, up 9.7% from $2.19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Delek Group deployed $87.9M of net new capital in Q1 2019, opening 42 new positions and adding to 72 existing holdings. Its largest new stake was Owens Corning: 500,000 shares worth $23.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $24.9M trimmed.
- Delek Group's largest Q1 2019 buy was Owens Corning: 500,000 shares worth $23.5M.
- Delek Group added most to Teva Pharmaceuticals in Q1 2019, an estimated $30.9M increase.
- Delek Group's biggest Q1 2019 reduction was Micron Technology, cutting an estimated $24.9M.
- Delek Group fully exited SodaStream International Ltd in Q1 2019, selling an estimated $13.8M.
- Delek Group's ten largest holdings make up 23% of its $2.41B portfolio in Q1 2019.
- Delek Group opened 42 new positions and closed 52 in Q1 2019.
- Delek Group's portfolio value rose 9.7% quarter-over-quarter to $2.41B.
Based on Delek Group's 13F filing for Q1 2019, filed 13 May 2019.